Theabsorbedradiationdosefrominternallydepositedradio nuclides is a major factor in assessing
risk and therapeutic utility when evaluating new radiopharmaceuticals for use in nuclear …

The availability of quantitative three-dimensional in vivo data on radionuclide distributions
within the body makes it possible to calculate the corresponding nonuniform distribution of …

The potential of α-particle emitters to treat cancer has been recognized since the early 1900s.
Advances in the targeted delivery of radionuclides and radionuclide conjugation chemistry…

This special report aims to inform the medical community about the many challenges involved
in managing radiation exposure in a way that maximizes the benefit-risk ratio. The report …

Radiation spectra for radionuclides currently provided by the MIRD Committee and ICRP do
not include the very low‐energy N‐ and O‐shell Auger electrons. These electrons, emitted …

The International Commission on Radiation Units and Measurements (ICRU) Report Committee
on “Bioeffect Modeling and Biologically Equivalent Dose Concepts in Radiation Therapy…

Methods Experimental range-energy relations for electrons and alpha particles, along with
derived geometric reduction factors, are used to calculate cellular absorbed fractions for …

The reliability of radiation dose estimates in internal radionuclide therapy is directly related
to the accuracy of activity estimates obtained at each imaging time point. The recently …

The present work systematically examines the self-dose and cross-dose contributions from
intracellularradioactiv ity within small micrometastases. Model calculations are performed to …

The biological effects of Auger‐electron‐emitting radionuclides can be as severe as those
of alpha particles of high linear energy transfer. A great deal of effort has been expended in …